Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation
- 1 February 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9151) , 468-469
- https://doi.org/10.1016/s0140-6736(98)05105-8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase ActivitiesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Human Serum ParaoxonaseGeneral Pharmacology: The Vascular System, 1998
- Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modificationPublished by Wiley ,1998
- DNA Polymorphisms in Two Paraoxonase Genes (PON1 and PON2) Are Associated with the Risk of Coronary Heart DiseaseAmerican Journal of Human Genetics, 1998
- The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidationBiochemical Journal, 1993